Submitting Advanced Bioanalytical Test Methods for Regulatory Approval - - BioPharm International

ADVERTISEMENT

Submitting Advanced Bioanalytical Test Methods for Regulatory Approval


BioPharm International


References:

1. Krause, SO. Qualifying Release Laboratories in Europe and the United States. BioPharm International 2004; 17 (3):28-36.

2. Krause, SO. Development and validation of analytical methods for biopharmaceuticals, part I: development and optimization. BioPharm International 2004; 17(10):52-61.

3. Krause, SO. Development and validation of analytical methods for biopharmaceuticals, part II: formal validation. BioPharm International 2004; 17(11):46-52.

4. Krause, SO. Analytical Method Validation for Biopharmaceuticals, BioPharm International, A Guide to Validation 2005; 24-32.

5. ICH. Validation of Analytical Procedures. Q2A. Federal Register 1995; 60.

6. ICH. Validation of Analytical Procedures: methodology. Q2B. Federal Register 1996; 62.


blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

NIH Seeks to Improve Vaccine Response with New Adjuvants
September 30, 2014
New Report Details Players and Pipelines in the Biosimilar Space
September 30, 2014
Baxter International Plans to Open R&D Center for Baxalta
September 30, 2014
FDA Releases First-Ever Purple Book for Biosimilar Characterization
September 26, 2014
FDA and NIH Win Award for IP Licensing of Meningitis Vaccine
September 26, 2014
Author Guidelines
Source: BioPharm International,
Click here